Scientists test new insulin shot in the belly
NCT ID NCT07341373
Summary
This early-stage study is testing the safety and performance of a new, concentrated insulin formulation. It involves 25 adults with Type 1 Diabetes. Researchers will inject the insulin into the abdomen and carefully monitor how the body absorbs it and controls blood sugar over 12 hours, comparing it to existing insulin products.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ProSciento, Inc.
RECRUITINGChula Vista, California, 91911, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.